Eisai
4523.T
#2173
Rank
โ‚น788.62 B
Marketcap
โ‚น2,798
Share price
0.67%
Change (1 day)
13.18%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น80.11. an increase over its 2024 EPS that were of โ‚น90.31.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น101.0111.85%
2024โ‚น90.31-32.63%
2023โ‚น134.055.52%
2022โ‚น127.04-74.01%
2021โ‚น488.74-66.58%
2020โ‚น1,46298.24%
2019โ‚น737.5917.01%
2018โ‚น630.3637.78%
2017โ‚น457.53-27.62%
2016โ‚น632.1335.33%
2015โ‚น467.10-2.82%
2014โ‚น480.67-27.66%
2013โ‚น664.50-27.49%
2012โ‚น916.47-12.67%
2011โ‚น1,04988.08%
2010โ‚น557.99-11.06%
2009โ‚น627.40-390.15%
2008-โ‚น216.24-127.78%
2007โ‚น778.4911.78%
2006โ‚น696.464.38%
2005โ‚น667.267.4%
2004โ‚น621.3143.03%
2003โ‚น434.4125.09%
2002โ‚น347.2752.67%
2001โ‚น227.4669.76%
2000โ‚น133.99